The data support the view that hormone modulation of DcR2 expression is involved in regulating TRAIL-induced apoptosis in the androgen-sensitive prostate carcinoma cell line, LNCaP, and provides preliminary insight into cell death induction in apoptosis resistant hormone-sensitive prostate cancer cells. Here, TNFRSF10D is linked to prostate carcinoma.